Immediate Discontinuation of Bupropion After Seizure
If a patient experiences seizure activity while taking bupropion 300 mg XR, discontinue the medication immediately and permanently—do not restart treatment. 1
Discontinuation Protocol
Stop bupropion abruptly without tapering. The FDA label is explicit: "Discontinue Wellbutrin XL and do not restart treatment if the patient experiences a seizure." 1 Unlike the gradual taper recommended for routine discontinuation (stepping down from 300 mg to 150 mg before stopping), seizure occurrence mandates immediate cessation regardless of dose.
Key Clinical Actions
- Immediate cessation: Stop all bupropion formulations at once
- No tapering required: The seizure risk outweighs any withdrawal concerns
- Permanent contraindication: Bupropion becomes contraindicated for this patient going forward 2, 1
- Ongoing monitoring: Continue supportive care and observation until any neuropsychiatric symptoms resolve, as some cases show persistent symptoms even after discontinuation 1
Clinical Context and Rationale
Bupropion is absolutely contraindicated in patients with seizure disorders or conditions that increase seizure risk 2, 1. The 300 mg daily dose represents the maximum recommended dose, with seizure incidence at approximately 0.1% (1/1000 patients) at this dose level 1. Once a seizure occurs, the patient has demonstrated they cannot safely tolerate bupropion at any dose.
Important Caveats
Do not attempt dose reduction or rechallenge. The FDA label and clinical guidelines are unambiguous—seizure occurrence is an absolute indication for permanent discontinuation 1. Case reports consistently demonstrate that seizures can occur even in patients without traditional risk factors 3, 4, and the drug's seizure-lowering effect persists regardless of dose adjustment.
Monitor for withdrawal symptoms, though these are typically mild with bupropion. The primary concern post-seizure is neurological stability, not antidepressant withdrawal. If the patient was using bupropion for depression, arrange immediate psychiatric follow-up to initiate alternative antidepressant therapy that does not lower seizure threshold.
Evaluate for contributing factors such as concomitant medications that lower seizure threshold (benzodiazepine withdrawal, other antidepressants, stimulants), metabolic abnormalities, or structural brain lesions 1, but this evaluation should not delay immediate discontinuation.